Newsroom

Displaying 31–40 of 143

February 5, 2026

Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

December 1, 2025

Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers

November 7, 2025

Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025

November 6, 2025

Seer Reports Third Quarter 2025 Financial Results

October 29, 2025

Seer to Participate in Upcoming November Investor Conferences

October 16, 2025

Seer to Report Third Quarter 2025 Financial Results on November 6, 2025

October 10, 2025

Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025

September 2, 2025

Seer Appoints Isaac Ro to its Board of Directors

August 26, 2025

Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

August 6, 2025

Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook

Starting your proteomics research is effortless

Connect with an expert to discuss which path to the full proteome is right for you.

  1. Bring the Proteograph Product Suite in-house
  2. Run a project with
    Seer Technology
    Access Center
  3. Conduct a project with
    a Seer service provider
    or Center of Excellence